不同DNA聚合酶对HBV PCR产物保真度的影响
被引量:1
摘要
PCR已广泛用于HBV感染标志物病毒DNA的定量检测,对PCR产物进行测序可分析HBV基因点突变,如检测拉夫米定等药物治疗诱导的与耐药相关的HBV基因点突变,研究乙型肝炎慢性化与转归的分子机制,分析基因多位点突变与HBV感染导致的肝细胞癌转移与复发的疾病预后的关系。PCR在HBV基因多位点突变的检测与研究中起重要作用。
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2010年第2期166-167,共2页
Chinese Journal of Laboratory Medicine
参考文献11
-
1魏来.HBV标志物定量和标准化是临床检测的方向[J].中华检验医学杂志,2009,32(9):967-970. 被引量:18
-
2许彪,李晓东,刘志国,毛远丽,胡瑾华,王业东,徐东平.建立一种PCR产物直接测序检测HBV YMDD突变的方法[J].中华检验医学杂志,2009,32(7):777-780. 被引量:2
-
3刘红艳,毛日成,李义良,夏佳慧,范丽丽,尹永喜,李新艳,赵旭,郭红英,朱浩翔,张继明.应用液相芯片技术检测拉米夫定耐药相关性HBV变异[J].中华检验医学杂志,2009,32(9):978-983. 被引量:1
-
4Qin Y, Zhang J, Mao R, et al. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAg titers. J Med Virol, 2009,81:807-814.
-
5Huang Y, Wang Z, An S, et al. Role of hepatitis B virus genotypes and quantitative HBV DNA in metastasis and recurrence of hepatocellular carcinoma. J Med Virol,2008,80:591-597.
-
6Bracho MA, Moya A, Barrio E. Contribution of Taq polymeraseinduced errors to the estimation of RNA virus diversity. J Gen Virol, 1998,79:2921-2928.
-
7Cline J, Braman JC, Hogrefe HH. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res, 1996,24:3546-3551.
-
8Eom SH, Wang J, Steitz TA. Structure of Taq polymerase with DNA at the polymerase active site. Nature, 1996,382:278-281.
-
9Shinde D, Lai Y, Sun F, et al. Taq DNA polymerase slippage mutation rates measured by PCR and quasi-likelihood analysis: (CA/GT) n and (A/T) n microsatellites. Nucleic Acids Res, 2003, 31 : 974-980.
-
10Kim SW, Kim DU, Kim JK, et al. Crystal structure of Pfu, the high fidelity DNA polymerase from Pyrococcus furiosus. Int J Biol Macromol, 2008,42:356-361.
二级参考文献5
-
1汪琳,赖平安,张鹤晓,周琦.液相芯片——高通量检测技术的新亮点[J].检验检疫科学,2005,15(6):55-56. 被引量:6
-
2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
-
3Jung Woo Shin,Neung Hwa Park,Seok Won Jung,Byung Chul Kim,Sung Ho Kwon,Jae Serk Park,In Du Jeong,Sung-Jo Bang,Do Ha Kim.Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive[J].World Journal of Gastroenterology,2006,12(41):6693-6698. 被引量:7
-
4何英,陆学东.液相芯片技术及其临床应用[J].国际检验医学杂志,2006,27(12):1107-1108. 被引量:14
-
5Xiao-li HOU,Han-liang JIANG,Qing-yi CAO,Li-ying ZHAO,Barbara J. CHANG,Zhi CHEN.Using oligonucleotide suspension arrays for laboratory identification of bacteria responsible for bacteremia[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2008,9(4):291-298. 被引量:4
共引文献18
-
1钟乔华,陈尤佳,谢细娜,姚宝胜.乙肝患者e抗原定量与HBV-DNA及ALT的相关性分析[J].中国实用医药,2010,5(9):39-40. 被引量:3
-
2杨瑞锋,魏来.乙型和丙型肝炎病毒核酸检测技术及进展[J].中华检验医学杂志,2010,33(5):476-480. 被引量:20
-
3苏义,王文庆.乙肝病毒拉米夫定耐药基因变异情况分析[J].中国煤炭工业医学杂志,2010,13(7):986-986. 被引量:3
-
4刘振玲.乙型肝炎病毒标志物实验室检测的研究进展[J].医学理论与实践,2011,24(8):893-895.
-
5魏来,杨瑞锋.乙型肝炎病毒e抗原定量检测的发展和意义[J].中华肝脏病杂志,2011,19(11):806-808. 被引量:6
-
6陈华根,黄学斌,宋强.时间分辨荧光免疫分析技术与酶联免疫吸附试验检测乙肝病毒血清标志物结果比较[J].医学信息,2011,24(23):360-360. 被引量:1
-
7张俊峰.慢性乙肝患者体内HBeAg、HBV DNA和肝功能指标检测结果分析[J].医药论坛杂志,2011,32(22):51-53. 被引量:2
-
8李金明,张瑞.常用乙型病毒性肝炎血清学标志物检测结果报告解释及临床应用[J].中华检验医学杂志,2012,35(4):296-300. 被引量:28
-
9朱华,邵永生.门诊人群乙型肝炎病毒血清标志物模式分析[J].中国煤炭工业医学杂志,2012,15(10):1530-1531.
-
10谭玉华,曾华,魏绍静,董梅,陈建起,袁国悦,李水珍,王佳佳,吴道贫.时间分辨荧光免疫法乙型肝炎病毒e抗原定量测定试剂盒的研制与性能评价[J].国际检验医学杂志,2012,33(18):2242-2244. 被引量:2
同被引文献14
-
1玉艳红,黄力毅,宣伟军.慢性肝病患者乙型肝炎病毒核心基因启动子变异与临床类型的相关性研究[J].广西医科大学学报,2007,24(3):370-372. 被引量:1
-
2Sato S, Suzuki K, Akahane Y, et al. Hepatitis B virus strain with mutations in the core promoter in patients with fulminant hepatitis[J]. Ann Intern Med, 1995,122 : 241-248.
-
3Buti M,Rodriguez Frias F,Jaedi R, et al. Hepatitis B virus genime variability and disease progression; the impact of precore mutants and genotypes[J]. J Clin Virol, 2005,34(S 1) : 79-82.
-
4Buckwold V E, Xu Z, Chen M, et al. Effects of a naturally oc- curring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication[J]. J Virol, 1996,70(9) :5845-5851.
-
5Morivama K, Okamoto H, Tsuda F, et al. Reduced precore tran- scription and enhanced core"pregenome transcription of hepatitis B virus DNA after replacement of the precorecore promoter with se quences associated with e antigen seronegative persistent infections [J]. Virology, 1996,226(2):269-280.
-
6Baumert T F, Marrone A, Vergalla J, et al. Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression[J]. J Virol, 1998,72(8) : 6785-6795.
-
7Liu C J,Chen B F,Chen P J,et al. Role of hepatitis B virus pre core/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study[J]. J Infect Dis, 2006,194(5) :594 -599.
-
8Marusawa H, Matsuzawa S, Welsh K, et al. HBXIP functions as a cofactor of surviving in apoptosis suppression[J]. EMBO J, 2003,22 (11) : 2729-2740.
-
9Block T M,Meha A S,fimmel C J,et al. Molecular viral on- cology of hepatocellular carcinoma [J ]. Oncogene, 2003, 22 (33) :5093- 5107.
-
10Heriyanto D S, Yano Y, Utsumi T, et al. Mutations within en hancer Ⅱ and BCP regions of hepatitis B virus in relation to advanced liver diseases in patients infected with subgenotype B3 in Indonesia[J]. J Med Virol,2012,84(1):44-51.
-
1覃桂芳,王少平,陆胜经.应用聚合酶链反应(PCR)检测乙型肝炎患者的HBV一DNA[J].广西预防医学,1995,1(2):89-90. 被引量:1
-
2高凤琴,薛敬东,李煜国,成冬生.痰热清治疗肝硬化腹水自发性腹膜炎38例[J].陕西医学杂志,2005,34(7):891-891. 被引量:6
-
3殷明伟,卞玉霞.中药治疗慢性病毒性乙型肝炎的体会[J].河南大学学报(医学科学版),2004,23(3):67-67. 被引量:1
-
4高辽平,贾秀岩,高学谦,高宪明.HBV感染的血清流行病学调查[J].中国公共卫生,2005,21(2):245-245. 被引量:5
-
5赵秀琴,沈荣,沈惠周.我院乙肝表面抗原(HBsAg)调查及管理[J].河北财经学院学报,1993,14(5):90-91.
-
6吴英,马珍,李科.HBV感染常见血清学模式分析[J].重庆医学,2007,36(1):69-70. 被引量:1
-
7王永太,冯顺,罗彩琴,王玉宝.银川市郊区HBV感染标志物血清流行病学调查和分析[J].宁夏医学杂志,1993,15(3):134-138.
-
8郝建平.拉米夫定联合乙肝疫苗治疗慢性乙肝疗效观察[J].基层医学论坛,2010,14(S1):49-49.
-
9卢广余.阿德福韦酯联合拉米夫定治疗慢性乙型肝炎40例临床观察[J].中国民族民间医药,2014,23(15):79-79. 被引量:1
-
10张晨.金水宝联合拉米夫定治疗慢性乙型肝炎疗效分析[J].陕西医学杂志,2012,41(7):871-872. 被引量:3